HKSE:2552
Hua Medicine (Shanghai) Ltd. · HKSE · Healthcare · HKD · FY for 2025
Figures on this page computed 2026-11-08 13:40 UTC
Last close
n/aHKD
Market data
1.7xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/mNet marginnet income exceeds revenue
Net income exceeds revenue.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
-12.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth124.4%97 of 100, above its sector
- Returns on capital109.9%99 of 100, above its sector
- Margins56.9%41 of 100, at its sector
- Price1.7x57 of 100, above its sector
- Safety6.1752 of 100, at its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Five bars, one line
lens 7 of 9Each against its own average
4 of 5 readExcept where said otherwise: Computed from the filing for 2025
- Sales4.96x
Its own average over 9 years, 99.4M.
- Profit-2.23x
Its own average over 10 years, -495.1M.
- Free cash flow0.52x
Its own average over 10 years, -115.1M.
- Debt0.87x
Its own average over 9 years, 344.9M.
- Pricen/a
Its own average over 0 years. Market data
Sales is furthest from its own average, at 4.96 times.
Sales is 4.96 times its own 9-year average; Profit is -2.23 times its own 10-year average; Free cash flow is 0.52 times its own 10-year average; Debt is 0.87 times its own 9-year average.
Every figure in this lens
Except where said otherwise: Computed from the filing for 2025
Sales against its own 9-year average4.96
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Profit against its own 10-year average-2.23
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Free cash flow against its own 10-year average0.52
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Debt against its own 9-year average0.87
- Source
- computed
- Statement
- income
- Fiscal year
- 2025
- Reported in
- CNY
Price against its own 0-year averagen/aMarket data
Not held.
- Source
- market
- Reported in
- HKD